Skip to main content
SpringerLink
Log in
Book cover

Osteochondral Tissue Engineering pp 241–253Cite as

PRP Therapy

  • Chapter
  • First Online:

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1059))

Abstract

Osteochondral lesions remain as a clinical challenge despite the advances in orthopedic regenerative strategies. Biologics, in particular, platelet-rich plasma, has been applied for the reparative and regenerative effect in many tissues, and osteochondral tissue is not an exception. Platelet-rich plasma is an autologous concentrate prepared from the collected blood; thus, this safe application is free of immune response or risk of transmission of disease. It has a high potential to promote regeneration, thanks to its content, and can be applied alone or can reinforce a tissue engineering strategy. The relevant works making use of platelet-rich plasma in osteochondral lesions are overviewed herein. The practical success of platelet-rich plasma is uncertain since there are many factors involved including but not limited to its preparation and administration method. Nevertheless, today, the issues and challenges of platelet-rich plasma have been well acknowledged by researchers and clinicians. Thus, it is believed that a consensus will be built it, and then with high-quality randomized controlled trials and standardized protocols, the efficacy of platelet-rich plasma therapy can be better evaluated.

Highlights

  • The need of treating the osteochondral lesions has not been yet met in the clinics.

  • Thanks to being an autologous source of growth factors, interleukins, and other cytokines and relative ease of clinical application, i.e., during a single-step surgical procedure, the use of platelet-rich plasma is of great interest.

  • The high theoretical potential of the role of platelet-rich plasma in the regeneration process of osteochondral lesions is known, and the efficiency needs to be confirmed by high-quality randomized controlled trials for a robust position in the treatments of osteochondral lesions in the clinics.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Dhillon MS, Patel S, John R (2017) PRP in OA knee–update, current confusions and future options. SICOT J 3:27

    Article  PubMed  PubMed Central  Google Scholar 

  2. Andia I, Abate M (2017) Platelet-rich plasma: combinational treatment modalities for musculoskeletal conditions. Front Med:1–14. https://rd.springer.com/article/10.1007/s11684-017-0551-6. DOI:10.1007/s11684-017-0551-6

    Article  PubMed  Google Scholar 

  3. Nguyen RT, Borg-Stein J, McInnis K (2011) Applications of platelet-rich plasma in musculoskeletal and sports medicine: an evidence-based approach. PM R 3(3):226–250

    Article  PubMed  Google Scholar 

  4. Engebretsen L, Steffen K, Alsousou J, Anitua E, Bachl N, Devilee R, Everts P, Hamilton B, Huard J, Jenoure P (2010) IOC consensus paper on the use of platelet-rich plasma in sports medicine. Br J Sports Med 44(15):1072–1081

    Article  PubMed  Google Scholar 

  5. Qureshi AH, Chaoji V, Maiguel D, Faridi MH, Barth CJ, Salem SM, Singhal M, Stoub D, Krastins B, Ogihara M (2009) Proteomic and phospho-proteomic profile of human platelets in basal, resting state: insights into integrin signaling. PLoS One 4(10):e7627

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Everts PA, Knape JT, Weibrich G, Schonberger J, Hoffmann J, Overdevest EP, Box HA, van Zundert A (2006) Platelet-rich plasma and platelet gel: a review. Journal of ExtraCorporeal. Technology 38(2):174

    Google Scholar 

  7. Marx RE (2001) Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent 10(4):225–228

    Article  CAS  PubMed  Google Scholar 

  8. Marx RE (2004) Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 62:489–496

    Article  PubMed  Google Scholar 

  9. Pietrzak WS, Eppley BL (2005) Platelet rich plasma: biology and new technology. J Craniofac Surg 16(6):1043–1054

    Article  PubMed  Google Scholar 

  10. Andia I, Maffulli N (2013) Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat Rev Rheumatol 9(12):721–730

    Article  CAS  PubMed  Google Scholar 

  11. Cengiz IF, Oliveira JM, Ochi M, Nakamae A, Adachi N, Reis RL (2017) “Biologic” treatment for meniscal repair. In: Injuries and health problems in football. Springer. Berlin, Heidelberg. 679–686

    Chapter  Google Scholar 

  12. Piuzzi NS, Chughtai M, Khlopas A, Harwin SF, Miniaci A, Mont MA, Muschler GF (2017) Platelet-rich plasma for the treatment of knee osteoarthritis: a review. J Knee Surg 30(07):627–633

    Article  PubMed  Google Scholar 

  13. Utku B, Dönmez G, Büyükdoğan K, Karanfil Y, Tolevska RD, Korkusuz F, Doral MN (2015) Platelet-rich plasma: from laboratory to the clinic. Sports injuries: prevention, diagnosis, treatment and. Rehabilitation:3223–3250

    Chapter  Google Scholar 

  14. Araki J, Jona M, Eto H, Aoi N, Kato H, Suga H, Doi K, Yatomi Y, Yoshimura K (2011) Optimized preparation method of platelet-concentrated plasma and noncoagulating platelet-derived factor concentrates: maximization of platelet concentration and removal of fibrinogen. Tissue Eng Part C Methods 18(3):176–185

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Cavallo C, Roffi A, Grigolo B, Mariani E, Pratelli L, Merli G, Kon E, Marcacci M, Filardo G (2016) Platelet-rich plasma: the choice of activation method affects the release of bioactive molecules. Biomed Res Int 2016:1

    Article  CAS  Google Scholar 

  16. Chahla J, Cinque ME, Piuzzi NS, Mannava S, Geeslin AG, Murray IR, Dornan GJ, Muschler GF, LaPrade RF (2017) A call for standardization in platelet-rich plasma preparation protocols and composition reporting: a systematic review of the clinical orthopaedic literature. JBJS 99(20):1769–1779

    Article  Google Scholar 

  17. Navani A, Li G, Chrystal J (2017) Platelet rich plasma in musculoskeletal pathology: a necessary rescue or a lost cause? Pain Physician 20(3):E345

    PubMed  Google Scholar 

  18. Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA (2009) Platelet-rich plasma from basic science to clinical applications. Am J Sports Med 37(11):2259–2272

    Article  PubMed  Google Scholar 

  19. Castillo TN, Pouliot MA, Kim HJ, Dragoo JL (2011) Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am J Sports Med 39(2):266–271

    Article  PubMed  Google Scholar 

  20. Ehrenfest DMD, Rasmusson L, Albrektsson T (2009) Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte-and platelet-rich fibrin (L-PRF). Trends Biotechnol 27(3):158–167

    Article  CAS  Google Scholar 

  21. Riboh JC, Saltzman BM, Yanke AB, Fortier L, Cole BJ (2016) Effect of leukocyte concentration on the efficacy of platelet-rich plasma in the treatment of knee osteoarthritis. Am J Sports Med 44(3):792–800

    Article  PubMed  Google Scholar 

  22. Fréchette J-P, Martineau I, Gagnon G (2005) Platelet-rich plasmas: growth factor content and roles in wound healing. J Dent Res 84(5):434–439

    Article  PubMed  Google Scholar 

  23. Cengiz IF, Oliveira JM, Reis RL (2014) Tissue engineering and regenerative medicine strategies for the treatment of osteochondral lesions. In: 3D multiscale physiological human. Springer, London pp 25–47

    Google Scholar 

  24. Yan L-P, Oliveira JM, Oliveira AL, Reis RL (2015) Current concepts and challenges in osteochondral tissue engineering and regenerative medicine. ACS Biomater Sci Eng 1(4):183–200

    Article  CAS  Google Scholar 

  25. Scioli MG, Bielli A, Gentile P, Cervelli V, Orlandi A (2017) Combined treatment with platelet-rich plasma and insulin favours chondrogenic and osteogenic differentiation of human adipose-derived stem cells in three-dimensional collagen scaffolds. J Tissue Eng Regen Med 11(8):2398–2410

    Article  CAS  PubMed  Google Scholar 

  26. Marmotti A, Bruzzone M, Bonasia D, Castoldi F, Rossi R, Piras L, Maiello A, Realmuto C, Peretti G (2012) One-step osteochondral repair with cartilage fragments in a composite scaffold. Knee Surg Sports Traumatol Arthrosc 20(12):2590–2601

    Article  CAS  PubMed  Google Scholar 

  27. Lee J-C, Min HJ, Park HJ, Lee S, Seong SC, Lee MC (2013) Synovial membrane–derived mesenchymal stem cells supported by platelet-rich plasma can repair osteochondral defects in a rabbit model. Arthroscopy: The Journal of Arthroscopic & Related Surgery 29(6):1034–1046

    Article  Google Scholar 

  28. Smyth NA, Haleem AM, Ross KA, Hannon CP, Murawski CD, Do HT, Kennedy JG (2016) Platelet-rich plasma may improve osteochondral donor site healing in a rabbit model. Cartilage 7(1):104–111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Altan E, Aydin K, Erkocak O, Senaran H, Ugras S (2014) The effect of platelet-rich plasma on osteochondral defects treated with mosaicplasty. Int Orthop 38(6):1321–1328

    Article  PubMed  PubMed Central  Google Scholar 

  30. Gormeli G, Karakaplan M, Gormeli CA, Sarikaya B, Elmali N, Ersoy Y (2015) Clinical effects of platelet-rich plasma and hyaluronic acid as an additional therapy for talar osteochondral lesions treated with microfracture surgery: a prospective randomized clinical trial. Foot Ankle Int 36(8):891–900

    Article  PubMed  Google Scholar 

  31. Guney A, Akar M, Karaman I, Oner M, Guney B (2015) Clinical outcomes of platelet rich plasma (PRP) as an adjunct to microfracture surgery in osteochondral lesions of the talus. Knee Surg Sports Traumatol Arthrosc 23(8):2384–2389

    Article  PubMed  Google Scholar 

  32. Guney A, Yurdakul E, Karaman I, Bilal O, Kafadar IH, Oner M (2016) Medium-term outcomes of mosaicplasty versus arthroscopic microfracture with or without platelet-rich plasma in the treatment of osteochondral lesions of the talus. Knee Surg Sports Traumatol Arthrosc 24(4):1293–1298

    Article  PubMed  Google Scholar 

  33. J-p S, Tanabe T, Tsuzuki N, Haneda S, Yamada K, Furuoka H, Tabata Y, Sasaki N (2013) Effects of bilayer gelatin/β-tricalcium phosphate sponges loaded with mesenchymal stem cells, chondrocytes, bone morphogenetic protein-2, and platelet rich plasma on osteochondral defects of the talus in horses. Res Vet Sci 95(3):1210–1216

    Article  CAS  Google Scholar 

  34. J-p S, Kambayashi Y, Itho M, Haneda S, Yamada K, Furuoka H, Tabata Y, Sasaki N (2015) Effects of a synovial flap and gelatin/β-tricalcium phosphate sponges loaded with mesenchymal stem cells, bone morphogenetic protein-2, and platelet rich plasma on equine osteochondral defects. Res Vet Sci 101:140–143

    Article  CAS  Google Scholar 

  35. Smyth NA, Haleem AM, Murawski CD, Do HT, Deland JT, Kennedy JG (2013) The effect of platelet-rich plasma on autologous osteochondral transplantation: an in vivo rabbit model. JBJS 95(24):2185–2193

    Article  Google Scholar 

  36. Betsch M, Schneppendahl J, Thuns S, Herten M, Sager M, Jungbluth P, Hakimi M, Wild M (2013) Bone marrow aspiration concentrate and platelet rich plasma for osteochondral repair in a porcine osteochondral defect model. PLoS One 8(8):e71602

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Sun Y, Feng Y, Zhang C, Chen S, Cheng X (2010) The regenerative effect of platelet-rich plasma on healing in large osteochondral defects. Int Orthop 34(4):589–597

    Article  CAS  PubMed  Google Scholar 

  38. Kon E, Filardo G, Delcogliano M, Fini M, Salamanna F, Giavaresi G, Martin I, Marcacci M (2010) Platelet autologous growth factors decrease the osteochondral regeneration capability of a collagen-hydroxyapatite scaffold in a sheep model. BMC Musculoskelet Disord 11(1):220

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. van Bergen CJ, Kerkhoffs GM, Özdemir M, Korstjens CM, Everts V, van Ruijven LJ, van Dijk CN, Blankevoort L (2013) Demineralized bone matrix and platelet-rich plasma do not improve healing of osteochondral defects of the talus: an experimental goat study. Osteoarthr Cartil 21(11):1746–1754

    Article  PubMed  Google Scholar 

  40. Xie X, Wang Y, Zhao C, Guo S, Liu S, Jia W, Tuan RS, Zhang C (2012) Comparative evaluation of MSCs from bone marrow and adipose tissue seeded in PRP-derived scaffold for cartilage regeneration. Biomaterials 33(29):7008–7018

    Article  CAS  PubMed  Google Scholar 

  41. Krych AJ, Nawabi DH, Farshad-Amacker NA, Jones KJ, Maak TG, Potter HG, Williams RJ III (2016) Bone marrow concentrate improves early cartilage phase maturation of a scaffold plug in the knee: a comparative magnetic resonance imaging analysis to platelet-rich plasma and control. Am J Sports Med 44(1):91–98

    Article  PubMed  Google Scholar 

  42. Gu W, Li T, Shi Z, Mei G, Xue J, Zou J, Wang X, Zhang H, Xu H (2017) Management of Hepple stage V osteochondral lesion of the talus with a platelet-rich plasma scaffold. Biomed Res Int 2017:1

    Google Scholar 

  43. Mei-Dan O, Carmont MR, Laver L, Mann G, Maffulli N, Nyska M (2012) Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med 40(3):534–541

    Article  PubMed  Google Scholar 

  44. Metcalf KB, Mandelbaum BR, McIlwraith CW (2013) Application of platelet-rich plasma to disorders of the knee joint. Cartilage 4(4):295–312

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Sheth U, Simunovic N, Klein G, Fu F, Einhorn TA, Schemitsch E, Ayeni OR, Bhandari M (2012) Efficacy of autologous platelet-rich plasma use for orthopaedic indications: a meta-analysis. J Bone Joint Surg 94(4):298–307

    Article  PubMed  Google Scholar 

  46. Nourissat G, Mainard D, Kelberine F, French Arthroscopic Society (SFA) (2013) Current concept for the use of PRP in arthroscopic surgery. Orthop Traumatol Surg Res 99(8):S407–S410

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work is a result of the project FROnTHERA (NORTE-01-0145-FEDER-000023), supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the Portugal 2020 Partnership Agreement, through the European Regional Development Fund (ERDF). IFC thanks the Portuguese Foundation for Science and Technology (FCT) for the PhD scholarship (SFRH/BD/99555/2014). JMO also thanks the FCT for the funds provided under the program Investigador FCT 2012 and 2015 (IF/00423/2012 and IF/01285/2015).

Author information

Authors and Affiliations

  1. 3B’s Research Group–Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Barco, Guimarães, Portugal

    Ibrahim Fatih Cengiz, J. Miguel Oliveira & Rui L. Reis

  2. ICVS/3B’s–PT Government Associate Laboratory, Braga/Guimarães, Portugal

    Ibrahim Fatih Cengiz, J. Miguel Oliveira & Rui L. Reis

  3. The Discoveries Centre for Regenerative and Precision Medicine, Headquarters at University of Minho, Barco/Guimarães, Portugal

    J. Miguel Oliveira & Rui L. Reis

Authors
  1. Ibrahim Fatih Cengiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Miguel Oliveira
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rui L. Reis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ibrahim Fatih Cengiz .

Editor information

Editors and Affiliations

  1. 3B’s Research Group – Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Barco, Guimarães, Portugal

    J. Miguel Oliveira

  2. 3B’s Research Group – Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Barco, Guimarães, Portugal

    Sandra Pina

  3. 3B’s Research Group – Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Barco, Guimarães, Portugal

    Rui L. Reis

  4. Polymeric Nanomaterials and Biomaterials Department, Institute of Polymer Science and Technology, Spanish Council for Scientific Research (CSIC), Madrid, Spain

    Julio San Roman

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Cengiz, I.F., Oliveira, J.M., Reis, R.L. (2018). PRP Therapy. In: Oliveira, J., Pina, S., Reis, R., San Roman, J. (eds) Osteochondral Tissue Engineering. Advances in Experimental Medicine and Biology, vol 1059. Springer, Cham. https://doi.org/10.1007/978-3-319-76735-2_11

Download citation

Publish with us

Policies and ethics

Search

Navigation